SPL Mapping FHIR R5 Implementation Guide, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 0.2.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-spl/ and changes regularly. See the Directory of published versions
Page standards status: Informative |
<RegulatedAuthorization xmlns="http://hl7.org/fhir">
<id value="Enbrel455Marketing"/>
<meta>
<profile
value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProductMarketing"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: RegulatedAuthorization Enbrel455Marketing</b></p><a name="Enbrel455Marketing"> </a><a name="hcEnbrel455Marketing"> </a><a name="Enbrel455Marketing-en-US"> </a><p><b>identifier</b>: <code>urn:oid:2.16.840.1.113883.3.150</code>/NDA103795</p><p><b>subject</b>: <a href="MedicinalProductDefinition-Enbrel455Definition.html">MedicinalProductDefinition: identifier = http://hl7.org/fhir/sid/ndc#National drug codes#58406-455; route = SUBCUTANEOUS</a></p><p><b>type</b>: <span title="Codes:{http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl C73594}">NDA</span></p><p><b>region</b>: <span title="Codes:{urn:iso:std:iso:3166 USA}">United States of America</span></p></div>
</text>
<identifier>
<system value="urn:oid:2.16.840.1.113883.3.150"/>
<value value="NDA103795"/>
</identifier>
<subject>🔗
<reference value="MedicinalProductDefinition/Enbrel455Definition"/>
</subject>
<type>
<coding>
<system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl"/>
<code value="C73594"/>
<display value="NDA"/>
</coding>
</type>
<region>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="USA"/>
</coding>
</region>
</RegulatedAuthorization>